Abeona Therapeutics Inc.ABEONASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year operating income growth rate
Latest
-5.38%
↑ 63% above average
Average (39q)
-14.62%
Historical baseline
Range
High:74.11%
Low:-213.69%
CAGR
+3.4%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -5.38% |
| Q2 2025 | -15.54% |
| Q1 2025 | -18.32% |
| Q4 2024 | -8.65% |
| Q3 2024 | 14.10% |
| Q2 2024 | -24.66% |
| Q1 2024 | -8.49% |
| Q4 2023 | -16.54% |
| Q3 2023 | -7.39% |
| Q2 2023 | 12.33% |
| Q1 2023 | 6.94% |
| Q4 2022 | -37.91% |
| Q3 2022 | -17.13% |
| Q2 2022 | 61.11% |
| Q1 2022 | 55.86% |
| Q4 2021 | -213.69% |
| Q3 2021 | -8.44% |
| Q2 2021 | 6.04% |
| Q1 2021 | -0.81% |
| Q4 2020 | -131.75% |
| Q3 2020 | 49.94% |
| Q2 2020 | 74.11% |
| Q1 2020 | -193.77% |
| Q4 2019 | 7.01% |
| Q3 2019 | 26.39% |
| Q2 2019 | -25.83% |
| Q1 2019 | 7.59% |
| Q4 2018 | -21.90% |
| Q3 2018 | -34.71% |
| Q2 2018 | -17.54% |
| Q1 2018 | -22.09% |
| Q4 2017 | -63.19% |
| Q3 2017 | 36.47% |
| Q2 2017 | -59.73% |
| Q1 2017 | 9.40% |
| Q4 2016 | -12.72% |
| Q3 2016 | 22.95% |
| Q2 2016 | -9.01% |
| Q1 2016 | 1.49% |
| Q4 2015 | -1.44% |